|
[1]HANDZLIK-ORLIK G, HOLECKI M, WILCZYNSKI K, et al.Osteoporosis in liver disease:pathogenesis and management[J].Ther Adv Endocrinol Metab, 2016, 7 (3) :128-135.
|
|
[2]SUZUKI H.Bone complications in chronic liver disease (hepatic osteodystrophy) [J].Clin Calcium, 2015, 25 (11) :1619-1624.
|
|
[3]LIU W, YANG LH, KONG XC, et al.Meta-analysis of osteoporosis:fracture risks, medication and treatment[J].Minerva Med, 2015, 106 (4) :203-214.
|
|
[4]STANG A.Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J].Eur J Epidemiol, 2010, 25 (9) :603-605.
|
|
[5]BANG UC, BENFIELD T, BENDTSEN F, et al.The risk of fractures among patients with cirrhosis or chronic pancreatitis[J].Clin Gastroenterol Hepatol, 2014, 12 (2) :320-326.
|
|
[6]TSAI CF, LIU CJ, CHEN TJ, et al.Increased incidence of orthopedic fractures in cirrhotic patients:a nationwide population-based study[J].J Hepatol, 2013, 58 (4) :706-714.
|
|
[7]ZHANG Q, CHENG J, ZHAO CS, et al.Epidemiologic study of osteoporotic vertebral compression fractures in patients with chronic hepatitis B[J].J Cervicodynia Lumbodynia, 2013, 34 (6) :441-444. (in Chinese) 张强, 成军, 赵昌松, 等.慢性乙型肝炎肝病患者骨质疏松性椎体压缩骨折的调查研究[J].颈腰痛杂志, 2013, 34 (6) :441-444.
|
|
[8]SOLAYMANI-DODARAN M, CARD TR, AITHAL GP, et al.Fracture risk in people with primary biliary cirrhosis:a population-based cohort study[J].Gastroenterology, 2006, 131 (6) :1752-1757.
|
|
[9]DIAMOND T, STIEL D, LUNZER M, et al.Osteoporosis and skeletal fractures in chronic liver disease[J].Gut, 1990, 31 (1) :82-87.
|
|
[10]YAKAR S, ROSEN CJ, BEAMER WG, et al.Circulating levels of IGF-1 directly regulate bone growth and density[J].J Clin Invest, 2002, 110 (6) :771-781.
|
|
[11]KAWELKE N, BENTMANN A, HACKL N, et al.Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation[J].J Bone Miner Res, 2008, 23 (8) :1278-1286.
|
|
[12]BENTMANN A, KAWELKE N, MOSS D, et al.Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function[J].J Bone Miner Res, 2010, 25 (4) :706-715.
|
|
[13]MOSCHEN AR, KASER A, STADLMANN S, et al.The RANKL/OPG system and bone mineral density in patients with chronic liver disease[J].J Hepatol, 2005, 43 (6) :973-983.
|
|
[14]SHAHIN AA, SHAKER OG, KAMAL N, et al.Circulating interleukin-6, soluble interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-10 levels in juvenile chronic arthritis:correlations with soft tissue vascularity assessed by power doppler sonography[J].Rheumatol Int, 2002, 22 (2) :84-88.
|
|
[15]CHEN CH, LIN CL, KAO CH.Association between chronic hepatitis B virus infection and risk of osteoporosis:a nationwide population-based study[J].Medicine (Baltimore) , 2015, 94 (50) :e2276.
|
|
[16]CHEN CH, LIN CL, KAO CH.Relation between hepatitis C virus exposure and risk of osteoporosis:a nationwide population-based study[J].Medicine (Baltimore) , 2015, 94 (47) :e2086.
|
|
[17]LOPEZ-LARRAMONA G, LUCENDO AJ, GONZALEZ-DELGADO L.Alcoholic liver disease and changes in bone mineral density[J].Rev Esp Enferm Dig, 2013, 105 (10) :609-621.
|
|
[18]GLASS LM, SU GL.Metabolic bone disease in primary biliary cirrhosis[J].Gastroenterol Clin North Am, 2016, 45 (2) :333-343.
|
|
[19]LIAO CC, CHEN TL.Risk and adverse outcomes of fractures in patients with liver cirrhosis:two nationwide studies[J].Hepatol Int, 2016, 10 (1) :s86-s87.
|
|
[20]SAEED NUS, GUL MA, SALIM A, et al.Frequency assessment of osteoporosis in patients of liver cirrhosis[J].Pak J Med Health Sci, 2015, 9 (1) :364-366.
|
DownLoad: